OPU-NET-DADENA: Optimized deep learning ensemble with u-net segmentation for early detection of diabetic retinopathy
Clinical Snapshot
PICO Framework
| P — Population | Patients with diabetes mellitus at risk of developing diabetic retinopathy |
| I — Intervention | OPU-NET-DADENA deep learning ensemble system with U-Net segmentation |
| C — Comparator | Previous deep learning methods for diabetic retinopathy detection |
| O — Outcomes | Diagnostic accuracy, sensitivity, specificity, precision, F-score for early diabetic retinopathy detection |
Bottom Line
This study presents a complex deep learning ensemble for diabetic retinopathy detection claiming 99.33% accuracy. However, the research suffers from significant methodological limitations that prevent confident clinical application. Critical diagnostic accuracy measures like sensitivity and specificity are missing, the reference standard is undefined, and no confidence intervals are provided. The study lacks external validation and sufficient detail for reproducibility. While the technical approach appears sophisticated, the absence of proper diagnostic study methodology makes it impossible to assess true clinical utility. Australian clinicians should await properly conducted diagnostic accuracy studies with appropriate reference standards, representative populations, and complete reporting of diagnostic performance measures before considering implementation in routine diabetic eye screening programs.
Key Findings
P Value: Not reported
Effect Size: 99.33% accuracy, 98.32% precision
Primary Outcome: Diagnostic accuracy for early diabetic retinopathy detection
Nnt Or Sensitivity: Sensitivity not reported - critical limitation for screening test
Confidence Interval: Not reported
Clinical Application
Requires MATLAB implementation and specialized technical expertise, limiting clinical deployment Could potentially support RACGP diabetes management guidelines for annual retinal screening, but requires validation against Australian population and integration with existing teleophthalmology programs Patients with diabetes mellitus requiring retinopathy screening
Abstract
One of the most significant microvascular complications of diabetes mellitus (DM) is diabetic retinopathy (DR). In the early stages, patients with DR may not exhibit any noticeable symptoms. It is a diabetic disorder that damages retinal blood vessels in the eyes. At first, there are no symptoms or sporadic visual issues. When it worsens, it affects both eyes and can lead to partial or total blindness. A person who already has DM is therefore constantly at a higher risk of developing the condition. Early identification can prevent the possibility of total and irreversible blindness. Therefore, needs an efficient and early diagnosis system. So, this paper proposes a new deep-learning methodology in a specific Deep Siamese DenseNet for early detection of DR. The proposed method is accomplished through various steps, such as Data Collection, Preprocessing, Augmentation, Segmentation, Feature Extraction, Feature Selection, and Detection. An adaptive histogram equalization approach named Contrast Limited Adaptive Histogram Equalization (CLAHE) is used to preprocess input images, which reduces amplification of noise. Then, the segmentation is done by the Optimized U-NETs. Next, features of the contrasted retinal images are extracted by residual attention EfficientNet (RA-EfficientNet). Then, the optimal features are selected by a hybrid Reptile Search Algorithm (RORS). Finally, the deep learning methodology includes DarkNet, DenseNet 201, and NasNetMobile used to detect diabetic retinopathy at an early stage. The model is implemented in MATLAB and evaluated using accuracy, precision, F-score, specificity, sensitivity, MCC, NPV, FPR, and FNR. The proposed approach achieves 99.33% accuracy and 98.32% precision, outperforming previous methods that reported accuracies of 95-97% and precisions of 94-96%, demonstrating its effectiveness for reliable early detection of DR.
Related Research
Indian journal of ophthalmology
Internet of things in assistive technology for people with visual impairment: A scoping review
1 Aug 2026
BMJ open ophthalmology
Screening for diabetic retinopathy with artificial intelligence in a primary care setting: a comparative cost analysis
1 Aug 2026
Science advances
Multispectral infrared-to-full-color upconversion expanding human vision
1 Aug 2026
This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service